BASF opens biocatalysed acrylamide plant in China
BASF has opened a new plant to produce biocatalysed acrylamide (BioACM) at its site in Nanjing Chemical Industrial Park, China.
The plant is capable of producing more than 50,000t of biocatalysed acrylamide annually, and has joined two other BioACM facilities owned by BASF in the US and England, UK.
Acrylamide is used in the manufacture of water-soluble flocculation aids that can make wastewater treatment and papermaking, as well as mineral processing and oil recovery methods less resource-intensive.
With the new enzyme-based plant, BASF intends to secure a quality source of supplying polyacrylamide to its customers in Asia-Pacific, especially China.
BASF also expects to improve the supply of cost-competitive acrylamide to the water-intensive industries.
BASF Paper and Water Chemicals senior vice-president Andreas Tuerk said: "The construction of a new polyacrylamide production line is currently underway and is expected to go on stream in 2018.
"With investments into upstream and downstream plants, we continue to strengthen our position as a leading partner for the paper and water treatment industries."
BASF further noted that enzyme-based biocatalytic production method produces less waste than conventional high-pressure, energy-intensive copper catalysis.
The process is designed to occur at room temperature and under normal atmospheric conditions, resulting in energy savings and generating fewer by-products.
Image: BASF opens the enzyme-based production plant for biocatalyzed acrylamide in Nanjing, China. Photo: © BASF SE.